Aptahem AB (publ) (APTA.ST)

SEK 1.6

(-3.03%)

Eps Summary of Aptahem AB (publ)

  • Aptahem AB (publ)'s latest annual eps in 2023 was -0.05 SEK , down -14.73% from previous year.
  • Aptahem AB (publ)'s latest quarterly eps in 2024 Q2 was -1.10 SEK , up 3.51% from previous quarter.
  • Aptahem AB (publ) reported an annual eps of -4.21 SEK in 2022, up 77.7% from previous year.
  • Aptahem AB (publ) reported an annual eps of -18.88 SEK in 2021, up 32.81% from previous year.
  • Aptahem AB (publ) reported a quarterly eps of -1.14 SEK for 2024 Q1, up 36.31% from previous quarter.
  • Aptahem AB (publ) reported a quarterly eps of N/A for 2023 FY, down -14.73% from previous quarter.

Annual Eps Chart of Aptahem AB (publ) (2023 - 2016)

Historical Annual Eps of Aptahem AB (publ) (2023 - 2016)

Year Eps Eps Growth
2023 -0.05 SEK -14.73%
2022 -4.21 SEK 77.7%
2021 -18.88 SEK 32.81%
2020 -28.10 SEK -5.68%
2019 -26.59 SEK 71.06%
2018 -91.88 SEK -121.02%
2017 -41.57 SEK -4.97%
2016 -39.60 SEK 0.0%

Peer Eps Comparison of Aptahem AB (publ)

Name Eps Eps Difference
Calliditas Therapeutics AB (publ) -8.69 SEK 99.444%
AcouSort AB (publ) -1.29 SEK 96.256%
Active Biotech AB (publ) -0.17 SEK 71.588%
Alzinova AB (publ) -0.41 SEK 88.22%
Amniotics AB (publ) -0.01 SEK -339.091%
Asarina Pharma AB (publ) -0.57 SEK 91.526%
BioArctic AB (publ) 2.60 SEK 101.858%
Camurus AB (publ) 7.78 SEK 100.621%
Cantargia AB (publ) -1.65 SEK 97.073%
Scandinavian ChemoTech AB (publ) -1.13 SEK 95.726%
Elicera Therapeutics AB (publ) -0.83 SEK 94.181%
Genovis AB (publ.) 0.94 SEK 105.138%
Guard Therapeutics International AB (publ) -11.26 SEK 99.571%
Mendus AB (publ) -4.40 SEK 98.902%
Kancera AB (publ) -0.80 SEK 93.963%
Karolinska Development AB (publ) 0.02 SEK 341.5%
LIDDS AB (publ) -0.63 SEK 92.333%
Lipum AB (publ) -4.45 SEK 98.915%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK 74.579%
Magle Chemoswed Holding AB (publ) 1.13 SEK 104.274%
Modus Therapeutics Holding AB (publ) -1.01 SEK 95.218%
NextCell Pharma AB -1.03 SEK 95.311%
OncoZenge AB (publ) -1.36 SEK 96.449%
Saniona AB (publ) -1.29 SEK 96.256%
Simris Alg AB (publ) -0.16 SEK 69.813%
Vicore Pharma Holding AB (publ) -3.22 SEK 98.5%
Xbrane Biopharma AB (publ) -1.27 SEK 96.197%
Xintela AB (publ) -0.13 SEK 62.846%
Ziccum AB (publ) -1.54 SEK 96.864%
Isofol Medical AB (publ) -0.23 SEK 79.0%
Xspray Pharma AB (publ) -6.76 SEK 99.286%
CombiGene AB (publ) -1.80 SEK 97.317%
Diamyd Medical AB (publ) -1.60 SEK 96.981%
Intervacc AB (publ) -1.69 SEK 97.142%
Alligator Bioscience AB (publ) -0.55 SEK 91.218%
Sprint Bioscience AB (publ) -0.01 SEK -666.667%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK 78.045%
Corline Biomedical AB -0.08 SEK 42.637%
IRLAB Therapeutics AB (publ) -3.43 SEK 98.592%
Bio-Works Technologies AB (publ) -1.57 SEK 96.924%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 99.515%
Fluicell AB (publ) -0.24 SEK 79.875%
Biovica International AB (publ) -2.14 SEK 97.743%
Spago Nanomedical AB (publ) -0.43 SEK 88.767%
Abliva AB (publ) -0.09 SEK 46.571%
Egetis Therapeutics AB (publ) -1.27 SEK 96.197%
2cureX AB (publ) -1.85 SEK 97.389%
I-Tech AB 1.70 SEK 102.841%
Hansa Biopharma AB (publ) -15.83 SEK 99.695%
Cyxone AB (publ) -0.22 SEK 78.045%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 97.561%
Biosergen AB -0.60 SEK 91.95%
Nanologica AB (publ) -2.05 SEK 97.644%
SynAct Pharma AB -6.64 SEK 99.273%
Annexin Pharmaceuticals AB (publ) -0.26 SEK 81.423%
BioInvent International AB (publ) -5.02 SEK 99.038%
Stayble Therapeutics AB (publ) -0.92 SEK 94.75%
Oncopeptides AB (publ) -1.96 SEK 97.536%
Pila Pharma AB (publ) -0.47 SEK 89.723%
Ascelia Pharma AB (publ) -3.24 SEK 98.509%
Diagonal Bio AB (publ) -0.32 SEK 84.906%